Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
335 hedge funds and large institutions have $1.64B invested in Avanos Medical in 2017 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 90 increasing their positions, 115 reducing their positions, and 51 closing their positions.
7% more capital invested
Capital invested by funds: $1.54B → $1.64B (+$103M)
3.21% more ownership
Funds ownership: 89.22% → 92.43% (+3.2%)
6% less call options, than puts
Call options by funds: $1.57M | Put options by funds: $1.67M
7% less funds holding
Funds holding: 360 → 335 (-25)
22% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 115
33% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 51
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$228M |
| 2 |
CRCP
Copper Rock Capital Partners
Boston,
Massachusetts
|
+$27.3M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$16.2M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$13M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shapiro Capital Management
Atlanta,
Georgia
|
-$6.45M |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$6.23M |
| 3 |
CSC
Cove Street Capital
El Segundo,
California
|
-$5.6M |
| 4 |
Morgan Stanley
New York
|
-$4.92M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$4M |
AVNS Hedge Fund Activity: Q1 2017 in Review
335 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2017, worth a combined $1.64B — up 6.7% from $1.54B a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of AVNS and 34 opened new positions — a net loss of 17 holders — while 115 trimmed existing stakes and 90 added.
The largest buyer was BlackRock, adding an estimated $228M. The largest seller was Shapiro Capital Management, cutting an estimated $6.45M.
- 335 institutional investors held Avanos Medical (AVNS) as of Q1 2017, down from 360 in Q4 2016.
- Funds reported $1.64B of Avanos Medical stock for Q1 2017, up 6.7% quarter-over-quarter.
- 34 funds opened new Avanos Medical positions in Q1 2017 and 51 closed out, a net change of -17 holders.
- The largest Avanos Medical buyer in Q1 2017 was BlackRock, an estimated $228M added.
- The largest Avanos Medical seller in Q1 2017 was Shapiro Capital Management, an estimated $6.45M sold.
Based on aggregated 13F filings for Q1 2017.